Starr Foundation Earmarks $100M for Cancer Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – The Starr Foundation said last week that it has set aside $100 million to create a consortium of five international research institutions with the goal of advancing the fight against cancer.

The consortium — called the Starr Cancer Consortium — includes the Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan-Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.